MINAPHARM Pharmaceuticals (EGX: MIPH)

MINAPHARM Pharmaceuticals Balance Sheet

Financials in millions EGP. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	3,264	1,918	1,694	981.94	1,024	764.02
Cash & Short-Term Investments	3,264	1,918	1,694	981.94	1,024	764.02
Cash Growth	93.06%	13.25%	72.47%	-4.06%	33.96%	-6.70%
Accounts Receivable	366.67	492.9	478.14	388.76	331.91	200.14
Other Receivables	18.49	17.56	12.22	5.52	5.67	6.02
Receivables	578.21	714.19	575.06	399.59	358.93	286.39
Inventory	1,268	1,055	838.28	668.51	587.16	481.24
Prepaid Expenses	32.43	10.76	12.41	6.54	5.89	4.34
Other Current Assets	299.76	344.49	524.8	345.77	205.54	163.67
Total Current Assets	5,442	4,042	3,644	2,402	2,181	1,700
Property, Plant & Equipment	5,200	4,251	2,685	1,340	1,004	899.91
Long-Term Investments	5	5	5	5	5	5
Goodwill	340.43	334.51	280.08	220.53	230.21	221.3
Other Intangible Assets	277.85	67.1	56.9	48.2	62.16	65.83
Long-Term Deferred Tax Assets	-	-	-	-	0.81	-
Other Long-Term Assets	4.84	3.22	134.67	89.77	-	-
Total Assets	11,270	8,704	6,806	4,106	3,483	2,892
Accounts Payable	958.98	707.54	677.29	416.64	508.39	304.84
Accrued Expenses	37.45	46.81	39.23	31.53	26.18	22.44
Short-Term Debt	2,985	2,071	1,042	542.29	747.41	791.82
Current Portion of Long-Term Debt	338.47	218.67	225.33	32.93	23.24	21.75
Current Portion of Leases	40.14	27.77	15.1	68.13	-	-
Current Income Taxes Payable	98.39	134.82	233.36	183.69	151.54	84.31
Current Unearned Revenue	15.01	9.81	7.45	5.04	4.44	8.67
Other Current Liabilities	309.93	314.7	261.3	208.89	168.76	162.8
Total Current Liabilities	4,784	3,531	2,501	1,489	1,630	1,397
Long-Term Debt	1,980	1,335	1,036	603.87	187.84	76.79
Long-Term Leases	215.86	153.62	114.83	1.17	-	-
Long-Term Deferred Tax Liabilities	62.61	44.99	56.01	22.69	18.53	26.19
Other Long-Term Liabilities	143.13	121.15	57.52	45.73	53.43	46.72
Total Liabilities	7,185	5,186	3,765	2,163	1,890	1,546
Common Stock	122.93	122.93	122.93	122.93	122.93	122.93
Retained Earnings	1,994	2,147	2,023	1,466	1,047	828.29
Treasury Stock	-69.63	-69.63	-69.63	-	-	-
Comprensive Income & Other	1,922	1,222	882.83	293.27	367.67	330.09
Total Common Equity	3,969	3,423	2,959	1,882	1,537	1,281
Minority Interest	115.81	94.61	81.82	61.29	56.04	64.04
Shareholders' Equity	4,085	3,517	3,041	1,943	1,593	1,345
Total Liabilities & Equity	11,270	8,704	6,806	4,106	3,483	2,892
Total Debt	5,560	3,806	2,433	1,248	958.49	890.36
Net Cash (Debt)	-2,296	-1,889	-739.64	-266.46	65.01	-126.34
Net Cash Per Share	-207.53	-170.70	-64.46	-21.67	5.29	-10.28
Filing Date Shares Outstanding	11.06	11.06	11.06	12.29	12.29	12.29
Total Common Shares Outstanding	11.06	11.06	11.06	12.29	12.29	12.29
Working Capital	658.27	511.26	1,143	913.2	551.05	303.03
Book Value Per Share	358.70	309.35	267.42	153.07	125.04	104.23
Tangible Book Value	3,350	3,021	2,622	1,613	1,245	994.19
Tangible Book Value Per Share	302.82	273.05	236.96	131.21	101.26	80.87
Land	54.36	39.7	33.23	26.15	27.3	26.24
Buildings	722.74	508.65	411.79	296.6	307.09	290.95
Machinery	2,448	1,777	1,365	977.94	961.26	875.36
Construction In Progress	3,347	2,936	1,666	666.97	357.47	268.1

Source: S&P Capital IQ. Standard template. Financial Sources.